Niacin and Heart Disease The New England Journal of Medicine reported on a trial of niacin in addition to a statin drug for people with heart problems. The "end point" was a combination of deaths, heart attacks, strokes, and similar problems. The investigators said that a total of 3414 patients were randomly assigned to receive niacin (1718) or placebo (1696). They also said that the end point was reached in
a. How many of the patients receiving the placebo reached the end point?
b. How many of the patients receiving the niacin reached the end point?
c. In the samples, did adding the niacin result in a slightly larger or a slightly smaller percentage of people reaching the end point?
d. Is this likely to have been a controlled experiment or an observational study?
Want to see the full answer?
Check out a sample textbook solutionChapter 12 Solutions
Introductory Statistics (2nd Edition)
Additional Math Textbook Solutions
Elementary Statistics: Picturing the World (6th Edition)
STATS:DATA+MODELS-W/DVD
Elementary Statistics (13th Edition)
Business Statistics: A First Course (8th Edition)
Statistical Techniques in Business and Economics
- Glencoe Algebra 1, Student Edition, 9780079039897...AlgebraISBN:9780079039897Author:CarterPublisher:McGraw HillHolt Mcdougal Larson Pre-algebra: Student Edition...AlgebraISBN:9780547587776Author:HOLT MCDOUGALPublisher:HOLT MCDOUGALCollege Algebra (MindTap Course List)AlgebraISBN:9781305652231Author:R. David Gustafson, Jeff HughesPublisher:Cengage Learning
- Algebra & Trigonometry with Analytic GeometryAlgebraISBN:9781133382119Author:SwokowskiPublisher:Cengage